NCT04971928
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +11 more
- Locations
-
- GSK Investigational Site Orlando, Florida, United States
- GSK Investigational Site San Antonio, Texas, United States
Clinical trial condition
Hepadnaviridae Infections
Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.
1,149 public trials
113 recruiting studies
Hepadnaviridae Infections trial results
NCT01251276
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
NCT05523648
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +18 more
- Locations
-
- Sichuan Leshan traditional Chinese medicine hospital Leshan, China
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- ENYO PHARMA Investigative site HK01 Hong Kong
- ENYO PHARMA Investigative site KR01 Busan, South Korea
- ENYO PHARMA Investigative site TW03 Kaohsiung City, Taiwan
- ENYO PHARMA Investigative site TW04 Kaohsiung City, Taiwan
NCT01970254
- Conditions
- Blood-Borne Infections, Cancer, Communicable Diseases, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04723602
- Conditions
- Acquired Immunodeficiency Syndrome, Acquired angioedema, Angioedema, +64 more
- Locations
-
- Oklahoma Blood Institute (OBI) Oklahoma City, Oklahoma, United States
Completed
Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children
NCT04188223
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Hasan Sadikin Hospital Bandung, West Java, Indonesia
NCT04490499
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Tampereen yliopisto Kokkolan rokotetutkimusklinikka ( Site 0009) Kokkola, Keski-Pohjanmaa, Finland
- Tampereen yliopisto Oulun rokotetutkimusklinikka ( Site 0004) Oulu, North Ostrobothnia, Finland
- Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0001) Tampere, Pirkanmaa, Finland
- Seinajoki Vaccine Research Center ( Site 0010) Seinajoki, Pohjanmaa, Finland
NCT04531098
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- National Institute of Hygiene and Epidemiology (NIHE) Hanoi, Vietnam
Completed
Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®
NCT04209400
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- Saint Petersburg State Budgetary Healthcare Institution Saint Petersburg, Mirgorodskaya, Russia